420 Lexington Avenue
Suite 350
New York, New York 10170
Telephone: 1.212.584.4180

Immune Modulation Program

Rebalancing the Immune System

NeoStem  is collaborating with the University of California, San Francisco (UCSF) on our Immune Modulation Program to pursue the development of cell therapies using a person’s immune cells as a therapeutic product to treat disorders of the immune system.

Many immune-mediated diseases are a result of an imbalance in the immune system whereby inflammatory cells go unchecked. Therapy using T regulatory cells (Tregs) represents a novel approach to restoring immune balance by enhancing Treg cell number and function to inhibit pathogenic immune responses.

Download NeoStem’s Treg Program Investor Summary and Article Packet.

T reg

NeoStem - Cell Therapy Development - Clinical